Oxford Coronavirus Vaccine
- All
- News
- Videos
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
- Monday May 6, 2024
- India News | Reported by Ashish Bhargava
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
- www.ndtv.com
-
Oxford Scientists To Study Effects Of Covid Variants, Shots In Pregnancy
- Tuesday February 15, 2022
- World News | Reuters
Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.
- www.ndtv.com
-
Lancet Study On Covishield Vaccine Protection Decline Is Misquoted: Experts
- Thursday December 23, 2021
- India News | Asian News International
The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.
- www.ndtv.com
-
On Omicron, AstraZeneca Says Booster Effective, Cites Oxford Lab Study
- Thursday December 23, 2021
- World News | Reuters
A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
- www.ndtv.com
-
Two-Dose Vaccines Induce Lower Antibodies Vs Omicron: Oxford Study
- Monday December 13, 2021
- World News | Reuters
Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be likely.
- www.ndtv.com
-
Does Omicron Defeat Vaccines? No Sign Of That Yet, Says Oxford
- Wednesday December 1, 2021
- World News | Suzi Ring, Bloomberg
There's no evidence existing vaccines won't provide some protection against the omicron variant, the University of Oxford said as scientists scramble to assess the new Covid-19 mutation.
- www.ndtv.com
-
Covid Poses Higher Risk Of Rare Brain Conditions Than Vaccines: Oxford-Led Study
- Tuesday October 26, 2021
- World News | Press Trust of India
COVID-19 is more likely to cause very rare neurological conditions than vaccination with the AstraZeneca or Pfizer preventives, according to a study led by the University of Oxford in the UK.
- www.ndtv.com
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
- Friday August 27, 2021
- World News | Press Trust of India
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
- www.ndtv.com
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
- Wednesday August 25, 2021
- World News | Reuters
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
- www.ndtv.com
-
Clotting Linked With AstraZeneca Vaccine Very Rare, Says Oxford Study
- Thursday August 12, 2021
- World News | Press Trust of India
The very rare blood clots that can be caused by the Oxford/AstraZeneca coronavirus vaccine can be aggressive and deadly but is very rare, leading scientists have concluded in the findings of the first study of its kind on Thursday.
- www.ndtv.com
-
Herd Immunity Not A Possibility With Delta Variant, Warns UK Vaccine Expert
- Wednesday August 11, 2021
- World News | Press Trust of India
The highly transmissible Delta variant of coronavirus has rendered the prospect of herd immunity, where the majority of a country's population becomes immune to a virus, difficult, the head of the UK's Oxford Vaccine Group has warned.
- www.ndtv.com
-
Two Doses Mostly Prevent Hospitalisation With Delta Variant: UK Body
- Monday June 14, 2021
- World News | Agence France-Presse
Two doses of COVID-19 vaccines are "highly effective" in preventing hospital admission with the Delta variant, Public Health England said on Monday.
- www.ndtv.com
-
Britain Seeks Extra AstraZeneca Shots To Combat "Beta" COVID-19 Variant
- Wednesday June 2, 2021
- World News | Reuters
Britain is in talks with Oxford and AstraZeneca for additional doses of their COVID-19 vaccine that has been modified to better target the "beta" coronavirus variant first identified in South Africa, and it will fund trials of the shots.
- www.ndtv.com
-
Even Single Vaccine Dose Cuts COVID-19 Infection Rate, New UK Study Finds
- Friday April 23, 2021
- World News | Press Trust of India
A single dose of either the Oxford/AstraZeneca or Pfizer/BioNTech vaccines, currently being administered in the UK, cut the rate of coronavirus infections by around 65 per cent, according to a new UK study on Friday.
- www.ndtv.com
-
Rare Blood Clot Risk Higher From Coronavirus Than Vaccine, Says UK Study
- Friday April 16, 2021
- World News | Press Trust of India
The risk of rare blood clotting following the COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza, according to a new University of Oxford study published on Thursday.
- www.ndtv.com
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
- Monday May 6, 2024
- India News | Reported by Ashish Bhargava
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
- www.ndtv.com
-
Oxford Scientists To Study Effects Of Covid Variants, Shots In Pregnancy
- Tuesday February 15, 2022
- World News | Reuters
Oxford University scientists said on Tuesday they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.
- www.ndtv.com
-
Lancet Study On Covishield Vaccine Protection Decline Is Misquoted: Experts
- Thursday December 23, 2021
- India News | Asian News International
The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.
- www.ndtv.com
-
On Omicron, AstraZeneca Says Booster Effective, Cites Oxford Lab Study
- Thursday December 23, 2021
- World News | Reuters
A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study.
- www.ndtv.com
-
Two-Dose Vaccines Induce Lower Antibodies Vs Omicron: Oxford Study
- Monday December 13, 2021
- World News | Reuters
Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be likely.
- www.ndtv.com
-
Does Omicron Defeat Vaccines? No Sign Of That Yet, Says Oxford
- Wednesday December 1, 2021
- World News | Suzi Ring, Bloomberg
There's no evidence existing vaccines won't provide some protection against the omicron variant, the University of Oxford said as scientists scramble to assess the new Covid-19 mutation.
- www.ndtv.com
-
Covid Poses Higher Risk Of Rare Brain Conditions Than Vaccines: Oxford-Led Study
- Tuesday October 26, 2021
- World News | Press Trust of India
COVID-19 is more likely to cause very rare neurological conditions than vaccination with the AstraZeneca or Pfizer preventives, according to a study led by the University of Oxford in the UK.
- www.ndtv.com
-
COVID-19 Has More Blood Clot Threat Than Vaccines, Says UK Study: Report
- Friday August 27, 2021
- World News | Press Trust of India
A coronavirus infection presents a much higher risk of developing a blood clot than the first dose of either the Oxford/AstraZeneca or the Pfizer/BioNTech jab, a large study led by the University of Oxford said on Friday.
- www.ndtv.com
-
Protection From Pfizer, AstraZeneca Jabs Wanes Within 6 Months: UK Study
- Wednesday August 25, 2021
- World News | Reuters
Protection against COVID-19 offered by two doses of the Pfizer/BioNTech and the Oxford/AstraZeneca coronavirus vaccines begins to fade within six months, underscoring the need for booster shots, according to researchers in Britain.
- www.ndtv.com
-
Clotting Linked With AstraZeneca Vaccine Very Rare, Says Oxford Study
- Thursday August 12, 2021
- World News | Press Trust of India
The very rare blood clots that can be caused by the Oxford/AstraZeneca coronavirus vaccine can be aggressive and deadly but is very rare, leading scientists have concluded in the findings of the first study of its kind on Thursday.
- www.ndtv.com
-
Herd Immunity Not A Possibility With Delta Variant, Warns UK Vaccine Expert
- Wednesday August 11, 2021
- World News | Press Trust of India
The highly transmissible Delta variant of coronavirus has rendered the prospect of herd immunity, where the majority of a country's population becomes immune to a virus, difficult, the head of the UK's Oxford Vaccine Group has warned.
- www.ndtv.com
-
Two Doses Mostly Prevent Hospitalisation With Delta Variant: UK Body
- Monday June 14, 2021
- World News | Agence France-Presse
Two doses of COVID-19 vaccines are "highly effective" in preventing hospital admission with the Delta variant, Public Health England said on Monday.
- www.ndtv.com
-
Britain Seeks Extra AstraZeneca Shots To Combat "Beta" COVID-19 Variant
- Wednesday June 2, 2021
- World News | Reuters
Britain is in talks with Oxford and AstraZeneca for additional doses of their COVID-19 vaccine that has been modified to better target the "beta" coronavirus variant first identified in South Africa, and it will fund trials of the shots.
- www.ndtv.com
-
Even Single Vaccine Dose Cuts COVID-19 Infection Rate, New UK Study Finds
- Friday April 23, 2021
- World News | Press Trust of India
A single dose of either the Oxford/AstraZeneca or Pfizer/BioNTech vaccines, currently being administered in the UK, cut the rate of coronavirus infections by around 65 per cent, according to a new UK study on Friday.
- www.ndtv.com
-
Rare Blood Clot Risk Higher From Coronavirus Than Vaccine, Says UK Study
- Friday April 16, 2021
- World News | Press Trust of India
The risk of rare blood clotting following the COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza, according to a new University of Oxford study published on Thursday.
- www.ndtv.com